Expertise in
14
conditions

Dr. Kenneth Sherman

Gastroenterology
Thoma & Sutton EyeCare Professionals LLC
222 Piedmont Ave, 
Cincinnati, OH 
41 Years of Experience
Expertise in
14
conditions
Thoma & Sutton EyeCare Professionals LLC
222 Piedmont Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kenneth Sherman is a Gastroenterologist in Cincinnati, Ohio. Dr. Sherman has been practicing medicine for over 41 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Hepatitis, Cirrhosis, Hepatitis C, Hepatitis E, and Liver Transplant.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in OH
Hospital Affiliations
Massachusetts General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO

Locations

Thoma & Sutton EyeCare Professionals LLC
222 Piedmont Ave, Cincinnati, OH 45219

Additional Areas of Focus

Dr. Sherman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Enrollment Status: Completed
Publish Date: December 06, 2021
Intervention Type: Drug
Study Phase: Phase 4
Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability & Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by EP in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability & Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by EP in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
Enrollment Status: Completed
Publish Date: October 15, 2019
Intervention Type: Biological, Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

174 Total Publications

Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.
Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 26, 2025
Similar Doctors
Expertise in
34
conditions
Dr. Andrew Ofosu
Gastroenterology
Expertise in
34
conditions
Dr. Andrew Ofosu
Gastroenterology

Thoma & Sutton EyeCare Professionals LLC

222 Piedmont Ave, 
Cincinnati, OH 
 (736.8 miles away)
513-475-7505
Languages Spoken:
English
See accepted insurances

Andrew Ofosu is a Gastroenterologist in Cincinnati, Ohio. Dr. Ofosu is highly rated in 34 conditions, according to our data. His top areas of expertise are Jaundice, Choledocholithiasis, Gastrointestinal Bleeding, Endoscopy, and Stent Placement.

Expertise in
25
conditions
Dr. Khurram Bari
Gastroenterology
Expertise in
25
conditions
Dr. Khurram Bari
Gastroenterology

Amsurg Cincinnati Anesthesia LLC

9275 Montgomery Rd, 
Montgomery, OH 
 (727.2 miles away)
513-475-7505
Languages Spoken:
English
See accepted insurances

Khurram Bari is a Gastroenterologist in Montgomery, Ohio. Dr. Bari is highly rated in 25 conditions, according to our data. His top areas of expertise are Hepatitis, Liver Failure, Ascites, Liver Transplant, and Endoscopy.

Expertise in
32
conditions
Dr. Christopher D. South
Gastroenterology | Hepatology
Expertise in
32
conditions
Dr. Christopher D. South
Gastroenterology | Hepatology

Gastro Health

4746 Montgomery Road, Suite 202, 
Cincinnati, OH 
 (733.5 miles away)
513-751-6667
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher South is a Hepatologist and a Gastroenterologist in Cincinnati, Ohio. Dr. South is highly rated in 32 conditions, according to our data. His top areas of expertise are Gardner Syndrome, Turcot Syndrome, Familial Adenomatous Polyposis, Gastrectomy, and Colonoscopy. Dr. South is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sherman's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile